VRNA

Verona Pharma
VRNA

Overview Fund Activity

125 hedge funds and large institutions have $957M invested in Verona Pharma in 2024 Q2 according to their latest regulatory filings, with 27 funds opening new positions, 43 increasing their positions, 33 reducing their positions, and 14 closing their positions.

Holders
125
Holders Change
+12
Holders Change %
+10.62%
% of All Funds
1.82%
Holding in Top 10
7
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.1%
New
27
Increased
43
Reduced
33
Closed
14
Calls
$10.8M
Puts
$10.5M
Net Calls
+$311K
Net Calls Change
+$608K

Top Buyers

1
MC
1
Maverick Capital
Texas
$44.7M
2
RCM
2
RA Capital Management
Massachusetts
$110M
3
T. Rowe Price Associates
3
T. Rowe Price Associates
Maryland
$13.7M
4
DTC
4
Deep Track Capital
Connecticut
$57.8M
5
CS
5
Candriam SCA
Luxembourg
$11.2M

Top Sellers

1
Wellington Management Group
1
Wellington Management Group
Massachusetts
$22.7M
2
EAM
2
Eventide Asset Management
Massachusetts
$7.63M
3
PA
3
Perceptive Advisors
New York
$35.2M
4
FTM
4
First Turn Management
California
$0
5
Fidelity Investments
5
Fidelity Investments
Massachusetts
$10.4M
Name Market Value Shares Shares
Change 		Shares
Change %
PBA
26
Paradigm Biocapital Advisors
New York
$10.4M 721,087 +721,087 New
Fidelity Investments
27
Fidelity Investments
Massachusetts
$10.4M 719,691 -1,011,662 -58%
AAA
28
Affinity Asset Advisors
New York
$10.1M 700,000 -117,833 -14%
Bank of America
29
Bank of America
North Carolina
$8.84M 611,018 +482,619 +376%
PHP
30
Parkman Healthcare Partners
Connecticut
$8.61M 595,389 +65,869 +12%
EAM
31
Eventide Asset Management
Massachusetts
$7.63M 527,781 -1,659,739 -76%
Millennium Management
32
Millennium Management
New York
$7.63M 527,640 +23,567 +5%
WP
33
Woodline Partners
California
$7.25M 501,198 -338,569 -40%
BlackRock
34
BlackRock
New York
$6.22M 430,429 +48,712 +13%
ClearBridge Investments
35
ClearBridge Investments
New York
$5.87M 405,819 +150,210 +59%
Legal & General Group
36
Legal & General Group
United Kingdom
$5.56M 384,208 +304,635 +383%
SB
37
Samsara BioCapital
California
$5.02M 347,500 – –
KCM
38
Kennedy Capital Management
Missouri
$4.88M 337,535 +214,320 +174%
BC
39
BIT Capital
Germany
$4.67M 322,870 -31,278 -9%
SCM
40
Silverarc Capital Management
Massachusetts
$4.4M 304,633 +167,919 +123%
MAP
41
Moody Aldrich Partners
Massachusetts
$4.28M 295,945 -18,967 -6%
RA
42
Rosalind Advisors
Ontario, Canada
$3.62M 250,000 – –
SSA
43
Schonfeld Strategic Advisors
New York
$3.21M 221,996 -38,204 -15%
AIM
44
Alerce Investment Management
Illinois
$3.08M 213,000 +213,000 New
DMKJ
45
David M. Knott Jr
$2.94M 203,000 +88,000 +77%
IC
46
Ikarian Capital
Texas
$2.91M 201,116 -174,194 -46%
KCM
47
Knoll Capital Management
Florida
$2.89M 200,000 – –
Prudential Financial
48
Prudential Financial
New Jersey
$2.56M 176,756 – –
Adage Capital Partners
49
Adage Capital Partners
Massachusetts
$2.53M 175,000 – –
JF
50
Jump Financial
Illinois
$2.44M 168,438 +153,709 +1,044%
1
2
3 4 5